118 related articles for article (PubMed ID: 34695078)
1. Which demographic factors influence Pacific women's attendance at colposcopy clinics in New Zealand?
McPherson G; Parmar P; Payne D; Fairbairn-Dunlop TP
N Z Med J; 2021 Oct; 134(1543):69-78. PubMed ID: 34695078
[TBL] [Abstract][Full Text] [Related]
2. Colposcopy attendance and deprivation: A retrospective analysis of 27,193 women in the NHS Cervical Screening Programme.
Douglas E; Wardle J; Massat NJ; Waller J
Br J Cancer; 2015 Jun; 113(1):119-22. PubMed ID: 25996205
[TBL] [Abstract][Full Text] [Related]
3. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
4. Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial.
Canfell K; Caruana M; Gebski V; Darlington-Brown J; Heley S; Brotherton J; Gertig D; Jennett CJ; Farnsworth A; Tan J; Wrede CD; Castle PE; Saville M
PLoS Med; 2017 Sep; 14(9):e1002388. PubMed ID: 28926579
[TBL] [Abstract][Full Text] [Related]
5. Inequity in timing of prenatal screening in New Zealand: Who are our most vulnerable?
Payne O; Pillai A; Wise M; Stone P
Aust N Z J Obstet Gynaecol; 2017 Dec; 57(6):609-616. PubMed ID: 28617944
[TBL] [Abstract][Full Text] [Related]
6. Who are the women who default from colposcopy clinics?
Usha Kiran TS; Jayawickrama NS
J Obstet Gynaecol; 2002 Sep; 22(5):537-9. PubMed ID: 12521425
[TBL] [Abstract][Full Text] [Related]
7. Cigarette smoking and the frequency of colposcopy visits, treatments and re-referral.
Lamb J; Dawson SI; Gagan MJ; Peddie D
Nurs Prax N Z; 2013 Mar; 29(1):24-33. PubMed ID: 23691758
[TBL] [Abstract][Full Text] [Related]
8. [Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors].
Ronco G; Biggeri A; Confortini M; Naldoni C; Segnan N; Sideri M; Zappa M; Zorzi M; Calvia M; Accetta G; Giordano L; Cogo C; Carozzi F; Gillio Tos A; Arbyn M; Mejier CJ; Snijders PJ; Cuzick J; Giorgi Rossi P
Epidemiol Prev; 2012; 36(3-4 Suppl 1):e1-72. PubMed ID: 22828243
[TBL] [Abstract][Full Text] [Related]
9. Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting.
Leinonen M; Nieminen P; Kotaniemi-Talonen L; Malila N; Tarkkanen J; Laurila P; Anttila A
J Natl Cancer Inst; 2009 Dec; 101(23):1612-23. PubMed ID: 19903804
[TBL] [Abstract][Full Text] [Related]
10. Trends in the diagnosis of high-grade cervical abnormalities in young women in the post-vaccination era.
Goyani AD; Innes CR; Simcock BJ; Harker D; Dudley NM; Eva L; Bergzoll C; MacNab H; Sykes PH
N Z Med J; 2020 Oct; 133(1524):50-63. PubMed ID: 33119570
[TBL] [Abstract][Full Text] [Related]
11. Patient age, ethnicity and waiting times determine the likelihood of non-attendance at a first specialist rheumatology assessment.
Milne V; Kearns R; Harrison A
Int J Rheum Dis; 2014 Jan; 17(1):19-25. PubMed ID: 24472262
[TBL] [Abstract][Full Text] [Related]
12. Cytological surveillance compared with immediate referral for colposcopy in management of women with low grade cervical abnormalities: multicentre randomised controlled trial.
TOMBOLA Group
BMJ; 2009 Jul; 339():b2546. PubMed ID: 19638646
[TBL] [Abstract][Full Text] [Related]
13. Who defaults from colposcopy? A multi-centre, population-based, prospective cohort study of predictors of non-attendance for follow-up among women with low-grade abnormal cervical cytology.
Sharp L; Cotton S; Thornton A; Gray N; Cruickshank M; Whynes D; Duncan I; Hammond R; Smart L; Little J
Eur J Obstet Gynecol Reprod Biol; 2012 Dec; 165(2):318-25. PubMed ID: 22921577
[TBL] [Abstract][Full Text] [Related]
14. Developing and piloting an intervention to reduce colposcopy non-attendance and corresponding inequalities: a mixed-methods study.
Cowling A; Nevens L; Contogiorgi N; Bradley N; Wilcockson C; Stebbings C; McMeekin P; Steer M; Harland J
Lancet; 2023 Nov; 402 Suppl 1():S35. PubMed ID: 37997076
[TBL] [Abstract][Full Text] [Related]
15. Findings and outcome of teenage women referred for colposcopy at Christchurch Women's Hospital, New Zealand.
Sykes P; Harker D; Peddie D
N Z Med J; 2005 Mar; 118(1211):U1350. PubMed ID: 15778751
[TBL] [Abstract][Full Text] [Related]
16. The impact of age and high-risk human papillomavirus (hrHPV) status on the prevalence of high-grade cervical intraepithelial neoplasia (CIN2+) in women with persistent hrHPV-positive, cytology-negative screening samples: a prospective cohort study.
Tidy JA; Lyon R; Ellis K; Macdonald M; Palmer JE
BJOG; 2020 Sep; 127(10):1260-1267. PubMed ID: 32279427
[TBL] [Abstract][Full Text] [Related]
17. Primary HPV screening for cervical cancer: Results after two screening rounds in a regional screening program in Finland.
Veijalainen O; Kares S; Kotaniemi-Talonen L; Kujala P; Vuento R; Luukkaala T; Kholová I; Mäenpää J
Acta Obstet Gynecol Scand; 2021 Mar; 100(3):403-409. PubMed ID: 33037625
[TBL] [Abstract][Full Text] [Related]
18. Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test.
Ronco G; Giorgi-Rossi P; Carozzi F; Confortini M; Dalla Palma P; Del Mistro A; Gillio-Tos A; Minucci D; Naldoni C; Rizzolo R; Schincaglia P; Volante R; Zappa M; Zorzi M; Cuzick J; Segnan N;
J Natl Cancer Inst; 2008 Apr; 100(7):492-501. PubMed ID: 18364502
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus test with cytology triage in organized screening for cervical cancer.
Veijalainen O; Kares S; Kujala P; Tirkkonen M; Vuento R; Kholová I; Luukkaala T; Osuala V; Mäenpää J
Acta Obstet Gynecol Scand; 2016 Nov; 95(11):1220-1227. PubMed ID: 27591407
[TBL] [Abstract][Full Text] [Related]
20. Feasibility and acceptability of telehealth and contactless delivery of human papillomavirus (HPV) self-testing for cervical screening with Māori and Pacific women in a COVID-19 outbreak in Aotearoa New Zealand.
Bartholomew K; Grant J; Maxwell A; Bromhead C; Gillett F; Saraf R; Moodabe K; Sherman SM; McPherson G; Flower D; Kathuria J; Crengle S; Massey R; Scott N; Coote P
N Z Med J; 2022 Nov; 135(1565):83-94. PubMed ID: 36356272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
